Perkins Capital Management’s BIO-key International BKYI Stock Holding History

Perkins Capital Management’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-17	Closed	-$13K	–	111
2019 Q4	$13K	Hold	17	–	–	0.01%	112
2019 Q3	$16K	Hold	17	–	–	0.01%	111
2019 Q2	$31K	Buy	+17	New	+$29.4K	0.02%	107
2019 Q1	–	Sell	-17	Closed	-$19K	–	127
2018 Q4	$19K	Hold	17	–	–	0.01%	124
2018 Q3	$35K	Buy	+17	New	+$47K	0.02%	129
2018 Q1	–	Sell	-17	Closed	-$44K	–	120
2017 Q4	$44K	Sell	17 -47	-73%	-$132K	0.04%	109
2017 Q3	$265K	Buy	+64	New	+$294K	0.28%	73

Other funds holding BKYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TrueWealth LLC Atlanta, Georgia $238M AUM 2.94% 1-Year Est. Return

Perkins Capital Management's BKYI Position: Q1 2020 in Review

Perkins Capital Management sold out of BIO-key International (BKYI) in Q1 2020, closing a stake of 17 shares — an estimated $13K sold.

Perkins Capital Management first reported a position in BKYI in Q3 2017 and held it in 7 quarters. The position peaked at $265K in Q3 2017. 3 funds tracked by Wall St. Rank hold BKYI as of Q1 2020.

Perkins Capital Management reported no remaining BIO-key International position as of Q1 2020 after selling out during the quarter.
Perkins Capital Management sold 17 BIO-key International shares in Q1 2020, an estimated $13K.
Perkins Capital Management first reported a position in BIO-key International in Q3 2017 and held it in 7 quarters.
Perkins Capital Management's BIO-key International position peaked at $265K in Q3 2017.
3 funds tracked by Wall St. Rank held BIO-key International as of Q1 2020.

Based on Perkins Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.